Početna › Rak (sve vrste) › Illinois
Kliničke studije za Rak (sve vrste) u državi Illinois
67 studija za Rak (sve vrste) traži sudionike na lokacijama u državi Illinois.
Gradovi u državi Illinois
- Chicago51 studija
- Cicero13 studija
- Evanston9 studija
- Peoria7 studija
- Champaign6 studija
- Springfield6 studija
- Naperville5 studija
- Waukegan4 studija
- Aurora4 studija
- Decatur4 studija
- Arlington Heights3 studija
- Bloomington3 studija
- Charleston3 studija
- Danville3 studija
- Carbondale3 studija
- Joliet3 studija
Službeni tekst studije (engleski)
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
- Hope and Healing Clinical Research LLC, Hinsdale
- Hope and Healing Clinical Research LLC, New Lenox
- Illinois Cancer Specialists, Niles
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07566156A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
- University of Chicago Medical Center /ID# 278863, Chicago
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 29. ruj 2026. · NCT07409246uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
- Northwestern University, Chicago
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 29. ruj 2026. · NCT05874921Registry Study for Radiation Therapy Outcomes
- OSF HealthCare Cancer Institute, Peoria
- Northwestern Medicine Chicago Proton Center, Warrenville
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 29. ruj 2026. · NCT01255748A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
- Investigative Site, Chicago
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT06881992A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- University of Illinois Chicago, Chicago
- Illinois Cancer Specialists, Niles
U tijeku regrutacijaFaza 3
Od 18 do 100 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT05920356A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Cancer Care Specialists of Illinois, Decatur
- Decatur Memorial Hospital, Decatur
- Hope and Healing Clinical Research LLC, Hinsdale
- i još 2
U tijeku regrutacijaFaza 2/3
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT06989437A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- Northwestern Memorial Hospital, Chicago
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 24. ruj 2026. · NCT06901531A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- University of Chicago Medical Center /ID# 280149, Chicago
- OSF St. Francis Medical Center /ID# 279930, Peoria
- Springfield Clinic - First /ID# 281309, Springfield
- i još 1
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT07365241TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- Cancer Treatment Centers of America-Chicago, Chicago
U tijeku regrutacijaFaza 2
Od 12 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT02693535Prospective Study to Assess a Diagnostic Aid for Cancer
- Christie Clinic, Champaign
- Hope and Healing Cancer Services, Hinsdale
- Springfield Clinic, Springfield
U tijeku regrutacijaOpažajna studija
Od 45 godina i više · Oba spola · Ažurirano 21. ruj 2026. · NCT07046260Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- Northwestern Memorial Hospital, Chicago
- University Of Chicago Medical Center, Chicago
U tijeku regrutacijaFaza 2/3
Sve dobne skupine · Oba spola · Ažurirano 18. ruj 2026. · NCT03435796RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Rush University Medical Center, Chicago
- University of Chicago Medical Center, Chicago
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 15. ruj 2026. · NCT07002034Evaluating the Communication Between Patients and Providers in Cancer Clinics
- Northwestern Memorial Hospital, Chicago
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 15. ruj 2026. · NCT06985953The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials
- Rush-Copley Medical Center, Aurora
- Advocate Good Shepherd Hospital, Barrington
- Carle BroMenn Outpatient Center, Bloomington
- i još 17
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 14. ruj 2026. · NCT06756607Falcon Real World Evidence Registry
- Endeavor Health, Evanston
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 50 do 80 godina · Oba spola · Ažurirano 11. ruj 2026. · NCT06589310A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)
- Northwestern University ( Site 0101), Chicago
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 11. ruj 2026. · NCT07030712A Phase 1/1b Study of IAM1363 in HER2 Cancers
- University of Chicago, Chicago
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT06253871Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- Carle Cancer Center, Urbana
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT05386108A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
- Research Site, Evanston
U tijeku regrutacijaFaza 3
Od 18 do 130 godina · Oba spola · Ažurirano 8. ruj 2026. · NCT07647328A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- University of Illinois at Chicago, Chicago
- University of Chicago Hospital, Chicago
- Springfield Clinic Main Campus, Springfield
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 8. ruj 2026. · NCT06119581A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
- Hope and Healing Cancer Services, Hinsdale
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 4. ruj 2026. · NCT07169851Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
- Insight Research Institute, Chicago
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 3. ruj 2026. · NCT06252649A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
- Northwestern University Feinberg School of Medicine, Chicago
- Cancer Care Specialists of Illinois, Decatur
- Illinois Cancer Care, Peoria
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 3. ruj 2026. · NCT06163534Ovarian Tissue Cryopreservation in Post Pubertal (OTC-Post Pubertal)
- Ann &Robert H Lurie Children's Hospital, Chicago
U tijeku regrutacijaOpažajna studija
Do 30 godina · Žene · Ažurirano 3. ruj 2026. · NCT05309746Ovarian Tissue Cryopreservation in Pre-Pubertal (OTC-Pre Pubertal)
- Ann & Robert H Lurie Childrens Hospital, Chicago
U tijeku regrutacijaOpažajna studija
Do 11 godina · Žene · Ažurirano 3. ruj 2026. · NCT05299710Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- Northwestern University, Chicago
- Southern Illinois University-Simmons, Springfield
- Carle Foundation Cancer Institute-Urbana, Urbana
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 2. ruj 2026. · NCT06072612Project: Every Child for Younger Patients With Cancer
- Rush-Copley Medical Center, Aurora
- Lurie Children's Hospital-Chicago, Chicago
- Northwestern University, Chicago
- i još 16
U tijeku regrutacijaOpažajna studija
Do 25 godina · Oba spola · Ažurirano 25. kol 2026. · NCT02402244Abatacept in Immune Checkpoint Inhibitor Myocarditis
- University of Chicago, Chicago
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 20. kol 2026. · NCT05335928Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies
- Site 05, Chicago
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 19. kol 2026. · NCT07276373A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- University of Chicago Medical Center, Chicago
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 19. kol 2026. · NCT04104776Tempus Open Link for Individual Voices in Innovative Analytics Registry: Platform Protocol for Multimodal Real-World Evidence in Cancer
- Tempus AI, Chicago
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Sve dobne skupine · Oba spola · Ažurirano 10. kol 2026. · NCT07756034International Rare Brain Tumor Registry
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
U tijeku regrutacijaOpažajna studija
Do 45 godina · Oba spola · Ažurirano 7. kol 2026. · NCT05697874A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
- Ann & Robert H Lurie Children's Hospital of Chicago, Chicago
U tijeku regrutacijaFaza 2
Od 1 do 39 godina · Oba spola · Ažurirano 7. kol 2026. · NCT05999994Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- OSF Saint Anthony's Health Center, Alton
- Rush-Copley Medical Center, Aurora
- Advocate Outpatient Center - Aurora, Aurora
- i još 58
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 7. kol 2026. · NCT06580314Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
- Lurie Children's Hospital, Chicago
U tijeku regrutacijaFaza 2
Od 1 do 26 godina · Oba spola · Ažurirano 4. kol 2026. · NCT07680439Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
- The University of Chicago Medicine, Chicago
U tijeku regrutacijaFaza 1/2
Od 12 godina i više · Oba spola · Ažurirano 14. srp 2026. · NCT05533697A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
- Hope And Healing Cancer Services /ID# 268536, Hinsdale
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 13. srp 2026. · NCT05650632A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
- University of Chicago Medical Center /ID# 274742, Chicago
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 10. srp 2026. · NCT07023289Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions
- Northwestern University, Chicago
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 10. srp 2026. · NCT07556380Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.